Prognostic Factors on Overall Survival of Newly Diagnosed Metastatic Nasopharyngeal Carcinoma |
Li, Jia-Xin
(Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, and State Key Laboratory of Oncology)
Huang, Shao-Min (Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, and State Key Laboratory of Oncology) Wen, Bi-Xiu (Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-Sen University) Lu, Tai-Xiang (Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, and State Key Laboratory of Oncology) |
1 | Lin S, Tham IW, Pan J, et al (2012). Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer. Am J Clin Oncol, 35, 474-9. DOI ScienceOn |
2 | Ngan RK, Yiu HH, Lau WH, et al (2002). Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study. Ann Oncol, 13, 1252-8. DOI ScienceOn |
3 | Cao X, He LR, Xie FY, et al (2011). Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit? BMC Cancer, 11, 370. DOI |
4 | Chan AT, Hsu MM, Goh BC, et al (2005). Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol, 23, 3568-76. DOI ScienceOn |
5 | Chen C, Wang FH, An X, et al (2013). Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma. Cancer Chemother Pharmacol, 71, 371-8. DOI ScienceOn |
6 | Chen C, Fei Z, Pan J, et al (2011). Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol, 41, 537-42. DOI ScienceOn |
7 | Khanfir A, Frikha M, Ghorbel A, et al (2006). Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases. Cancer Radiother, 10, 545-9. DOI ScienceOn |
8 | Chen MK, Chen TH, Liu JP, et al (2004). Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer, 100, 2160-6. DOI ScienceOn |
9 | Fandi A, Bachouchi M, Azli N, et al (2000). Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J Clin Oncol, 18, 1324-30. DOI |
10 | Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK (1995). The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys, 33, 281-7. DOI ScienceOn |
11 | Lee AW, Poon YF, Foo W, et al (1992). Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys, 23, 261-70. DOI ScienceOn |
12 | Lee CC, Chu ST, Ho HC, et al (2008). Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma. Acta Otolaryngol, 128, 93-7. DOI ScienceOn |
13 | Leong SS, Wee J, Rajan S, et al (2008). Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma. Cancer, 113, 1332-7. DOI ScienceOn |
14 | Teo PM, Kwan WH, Lee WY, et al (1996). Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer, 77, 2423-31. DOI |
15 | Phua Chee Ee V1, Tan BS, Tan AL, et al (2013). Dose planning study of target volume coverage with intensity- modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience. Asian Pac J Cancer Prev, 14, 2243-8. 과학기술학회마을 DOI ScienceOn |
16 | Pan CC, Lu J, Yu JR, et al (2012). Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp Ther Med, 4, 334-8. DOI |
17 | Peng G, Wang T, Yang KY, et al (2012). A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol, 104, 286-93. DOI ScienceOn |
18 | Siu LL, Czaykowshi PM, Tannock IF (1998). Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx. J Clin Oncol, 16, 2514-21. DOI |
19 | Sobin LH, Gospodaroeics MK, Wittekind Ch (2009). TNM Classification of Malignant Tumours, 7th edition. New York, US: Wiley Press. |
20 | Toh CK, Heng D, Ong YK, et al (2005). Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma. Br J Cancer, 92, 1382-7. DOI ScienceOn |
21 | Wei K, Xu Y, Liu J, Zhang W, Liang Z (2010). No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007. Asian Pac J Cancer Prev, 11, 1595-9. |
22 | Parkin DM, Whelan SL, Ferlay J, et al (1997). Cancer incidence in five continents, vol. VII. Lyon, France: IRAC Scientific Publications Number, 143, 334-7. |